Search results
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 5 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
High price of popular diabetes drugs deprives low-income people of effective treatment
Daily Montanan via Yahoo News· 1 day agoFor the past year-and-a-half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes,...
Researchers determine timing is key for type 2 diabetes drug performance
Medical Xpress· 2 days agoDr. Cong Xie postdoctoral research fellow in the Centre of Research Excellence in Translating Nutritional Science to Good Health, at Adelaide Medical School, worked with Associate Professor ...
Popular diet and diabetes drugs in short supply as demand surges
AOL· 6 days agoWeight loss drugs like Ozempic, Wegovy and Zepbound continue to be in short supply. The weekly...
Diabetes drug metformin may be as safe as insulin during pregnancy
Medical News Today· 7 days agoResearchers have concluded that the oral diabetes medication metformin is just as safe for babies...
Diabetes drug recommended to treat obesity on the NHS
Press Association News via AOL· 6 days agoThe type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS....
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 3 days agoHowever, another drug designed to assist with type 2 diabetes treatment, metformin, had a 13-year...
Should Wegovy, the $400-a-month obesity medication, be covered by the provinces?
CBC via Yahoo News· 6 days agoThe popular weight-loss drug Wegovy has been available in Canada since early May, but anybody hoping...
U.S. FDA places clinical hold on Biomea's diabetes trials
AOL· 3 days agoThe drug, BMF-219, was being tested in an early-to-mid stage study for type 2 diabetes and a mid-stage study in type 1 diabetes. The ...
Trillion Dollar Shot
The Wall Street Journal· 13 hours agoThey tell the story of how an underfunded program to develop a new diabetes treatment turned into a blockbuster drug, largely because of one scientist’s...
